FDA should regulate kratom as a dietary ingredient rather than the health threat the agency claims it is, not only due to its history of safe use similar to other botanicals but also because like other supplement ingredients, some products labeled as kratom are adulterated and should be removed from the market, experts say.
Now that FDA has completed its evaluations of two compounds in kratom – mitragynine and 7-hydroxymitragynine – that the Drug Enforcement Administration has proposed to schedule as controlled substances, researchers who attest to the ingredient's safety and its value in helping opioid abusers through withdrawal or as a natural pain reliever or mood enhancer say time could be running
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?